Primary epithelial-myoepithelial carcinoma (EMC) of the lung is an extremely rare neoplasm that originates from submucosal bronchial glands and has been found in the salivary glands, breast tissue, and sweat glands. However, only a few cases in the respiratory tract have been identified. In the literature, most pulmonary EMCs have been reported to have developed endobronchially although a few EMC cases have been presented as intraparenchymatous tumors. We have identified a case of primary EMC that developed in the peripheral lung parenchyma.
pneumonia. There were no palpable adenopathies, and cardiopulmonary auscultation and laboratory study results, including an electrocardiogram and blood analysis, were within reference limits. A chest radiograph showed a mass 3.2×2.8 cm in size in the left peripheral lung field. A chest computed tomography (CT) scan revealed a well-defined mass of 3×2.9 cm that bordered the visceral pleura at the lingular segment of the left upper lobe (LUL) (Fig. 1A, B) . A percutaneous needle biopsy was performed, and the diagnosis indicated that the mass was a salivary gland tumor. Positron emission tomography (PET)-CT revealed a LUL mass with a maximal standardized uptake value of 3.2 and uptake, which indicated distant metastasis. The patient was treated by a lobectomy of the left upper lung with lymph node dissection via video-assisted thoracic surgery. Grossly, the excised section of the left upper lung showed a well-circumscribed, gray-white to yellow tumor mass, measuring 3.3×2.4×1.9 cm (Fig. 2) . A microscopic examination revealed that the cut section of the tu- A few mitotic figures were also seen (H&E, ×400) (Fig. 3A,   B ). Immunochemical staining for epithelial membrane antigen was positive in the inner tubular layers and epithelial components (EMA, ×200). Immunostaining for actin was positive in the outer tubular layer and solid areas (Actin, ×200). Immunostaining for S-100 showed a focal positive reaction in the outer tubular layer and solid areas (S-100, ×200) ( The submucosal tracheobronchial glands, which are the pulmonary equivalent of the minor salivary gland system of the head, neck, and breast, and of most other tumors that develop, originate from these glands. However, EMC is rarely found in the respiratory tract. A review of the literature reveals that the incidence of primary lung EMC does not exceed thirty cases worldwide, and most of these cases have been presented as polypoid endobronchial masses [2] . In Korea, Cho et al. [3] were the first to report a case of primary endobronchial epithelial-myoepithelial carcinoma. Munoz et al. [4] was the first to describe EMC that developed in the lung parenchyma without any connection to other visceral pleura or the bronchial tree. In our case, the tumor demonstrated peripheral parenchymal development without a bronchial connection and was also characterized by visceral pleura invasion. An epithelial-myoepithelial carcinoma diagnosis is based on pathological characteristics, including tubular differentiation with a mixture of epithelial and myoepithelial cells. ver, and recurrent pneumonia can occur, while thoracic pain may occur in EMC that develops peripherally [5, 6] . In this case, unlike previous reports, the tumor was identified before symptoms developed in the patient due to the location. A percutaneous needle biopsy was performed preoperatively, and the pathological findings suggested a salivary gland-like tumor. Based on these results, we decided to perform a left upper lobe lobectomy with lymph node dissection. The patho-
